Saturday, November 16, 2013
Work the researchers to improve the outcomes of patients with lymphoma.
University of Nebraska Medical Center （ Fred & Pamela Buffett cancer center headquartered ） of researchers are diffuse large B cell lymphoma patient they discovered that do not respond to standard drug therapy used to treat this type of cancer if you have a high level of gene called STAT3. Findings will be published in medical journal 11 issue of the journal Clinical Oncology, Clinical Oncology, American society.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment